Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
2013 · Gut · 451 citations
https://doi.org/10.1136/gutjnl-2013-305279
O
Ole Østergaard Thomsen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
7.5K
Citations
34
h-index
56
i10-index
Ole Østergaard Thomsen is an academic researcher from Gentofte Hospital. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 34, co-authored 107 publications.
Papers by this author
worksComparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease
2013 · Therapeutic Drug Monitoring · 114 citations
https://doi.org/10.1097/ftd.0b013e31828d23c3
Persistence of antibodies to pneumococcal conjugate vaccine compared to polysaccharide vaccine in patients with Crohn’s disease – one year follow up
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8851484.v1
Persistence of antibodies to pneumococcal conjugate vaccine compared to polysaccharide vaccine in patients with Crohn’s disease – one year follow up
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8851484
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat